Faga Daniel

CIK 00016735283 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001673528

Recent Transactions

50 trades

Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2026-01-08$44.71/sh−14,281→ 479,344 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-01-07−26,838→ 80,512 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2026-01-07+26,838→ 493,625 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2026-01-07$45.11/sh−9,202→ 466,787 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-01-06+98,600→ 98,600 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-01-06+133,400→ 133,400 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2026-01-06+17,850→ 475,989 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-01-06−17,850→ 17,850 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2026-01-05$43.26/sh−15,309→ 458,139 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-01-03−34,677→ 69,355 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2026-01-03+34,677→ 473,448 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2025-01-07+107,350→ 107,350 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2025-01-07+305,500→ 305,500 total
Tax Payment
ANAPTYSBIO, INC$ANAB
Common Stock
2025-01-06$15.30/sh−6,387→ 436,466 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2025-01-06+17,850→ 442,853 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2025-01-06−17,850→ 35,700 total
Tax Payment
ANAPTYSBIO, INC$ANAB
Common Stock
2025-01-03$14.60/sh−13,033→ 425,003 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2025-01-03+34,678→ 438,036 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2025-01-03−34,678→ 104,032 total
Award
ANAPTYSBIO, INC$ANAB
Common Stock
2024-07-22+160,000→ 160,000 total
Tax Payment
ANAPTYSBIO, INC$ANAB
Common Stock
2024-03-26$21.60/sh−347,441→ 401,646 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2024-03-25$21.42/sh−3,000→ 749,087 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2024-03-22$22.78/sh−145,940→ 752,087 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2024-01-08$21.81/sh−6,866→ 898,027 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-01-06−17,850→ 53,550 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2024-01-06+17,850→ 904,893 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-01-03+138,710→ 138,710 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2024-01-03+379,620→ 379,620 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-01-06+71,400→ 71,400 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-01-06+194,900→ 194,900 total
Award
ANAPTYSBIO, INC$ANAB
Common Stock
2022-03-21+887,043→ 887,043 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2022-02-10+9,200→ 9,200 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (Right to Buy)
2021-11-26+2,321→ 2,321 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (Right to Buy)
2021-11-26+11,000→ 11,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-02-02$194.38/sh−1,340→ 30,638 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-02-02$114.33/sh+1,340→ 31,978 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2021-02-02−1,340→ 63,630 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-01-15+10,979→ 10,979 total
Award
Mirati Therapeutics, Inc.
Common Stock
2021-01-15+7,023→ 30,638 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-01-07$216.33/sh−2,613→ 23,615 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-01-07$215.31/sh−12→ 26,228 total
Award
Mirati Therapeutics, Inc.
Common Stock
2020-01-06+26,240→ 26,240 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2020-01-06+64,970→ 64,970 total
Disposition from Tender
Spark Therapeutics, Inc.
Common Stock
2019-12-17$114.50/sh−38,828→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−26,250→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Restricted Stock Units
2019-12-17−21,500→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−35,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−50,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−14,000→ 0 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-25−80,000→ 50,000 total

Companies

Recent Filings

Address

C/O ANAPTYSBIO, INC. 10770 WATERIDGE CIRCLE, SUITE 210

SAN DIEGO, CA, 92121

View on SEC.gov